Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Wilding

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Science (London, England : 1979)|October 24, 2001
Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerolsE K Naderali, M J Brown, L C Pickavance, et al.
Clinical Endocrinology|February 24, 2012
A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitusS K Thondam, D J Cuthbertson, B S Aditya, et al.
International Journal of Obesity (2005)|January 13, 2017
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?D J Cuthbertson, T Steele, J P Wilding, et al.
European Journal of Clinical Investigation|June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitusJ F Todd, J P Wilding, C M Edwards, et al.
Peptides|May 1, 1992
Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in ratsJ P Wilding, S G Gilbey, P M Jones, et al.
Peptides|January 1, 1994
Naloxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: evidence for neuropeptide Y-opioid interactions in the control of food intakeP D Lambert, J P Wilding, A A al-Dokhayel, et al.
Diabetologia|February 1, 1994
Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humansJ P Wilding, N Khandan-Nia, W M Bennet, et al.
Endocrinology|July 1, 1993
A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivationP D Lambert, J P Wilding, A A al-Dokhayel, et al.
Endocrinology|May 1, 1993
Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouseJ P Wilding, S G Gilbey, C J Bailey, et al.
Archives of Internal Medicine|May 16, 2000
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adultsS B Heymsfield, K R Segal, J Hauptman, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Science (London, England : 1979)|October 24, 2001
Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerolsE K Naderali, M J Brown, L C Pickavance, et al.
Clinical Endocrinology|February 24, 2012
A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitusS K Thondam, D J Cuthbertson, B S Aditya, et al.
International Journal of Obesity (2005)|January 13, 2017
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?D J Cuthbertson, T Steele, J P Wilding, et al.
European Journal of Clinical Investigation|June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitusJ F Todd, J P Wilding, C M Edwards, et al.
Peptides|May 1, 1992
Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in ratsJ P Wilding, S G Gilbey, P M Jones, et al.
Peptides|January 1, 1994
Naloxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: evidence for neuropeptide Y-opioid interactions in the control of food intakeP D Lambert, J P Wilding, A A al-Dokhayel, et al.
Diabetologia|February 1, 1994
Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humansJ P Wilding, N Khandan-Nia, W M Bennet, et al.
Endocrinology|July 1, 1993
A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivationP D Lambert, J P Wilding, A A al-Dokhayel, et al.
Endocrinology|May 1, 1993
Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouseJ P Wilding, S G Gilbey, C J Bailey, et al.
Archives of Internal Medicine|May 16, 2000
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adultsS B Heymsfield, K R Segal, J Hauptman, et al.
Pageof 4